Roberto Vidal

Prof. Roberto Vidal

Universidad de Chile
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ABAna Batista-Gonzalez
Ana Batista-Gonzalez
Roberto VidalRoberto Vidal
Roberto Vidal
ACAlfredo Criollo
Alfredo Criollo
Leandro J. CarreñoLeandro J. Carreño
Leandro J. Carreño
Macrophage activation is intimately linked to metabolic reprogramming. Inflammatory (M1) macrophages are able to sustain inflammatory responses and to kill pathogens, mostly by relying on aerobic glycolysis and fatty acid biosynthesis. Glycolysis is a fast way of producing ATP, and fatty acids serve as precursors for the synthesis of inflammatory mediators. On the opposite side, anti-inflammatory (M2) macrophages mediate the resolution of inflammation and tissue repair, switching their metabolism to fatty acid oxidation and oxidative phosphorylation. Over the years, this classical view has been challenged by recent discoveries pointing to a more complex metabolic network during macrophage activation. Lipid metabolism plays a critical role in the activation of both M1 and M2 macrophages. Recent evidence shows that fatty acid oxidation is also essential for inflammasome activation in M1 macrophages, and glycolysis is now known to fuel fatty acid oxidation in M2 macrophages. Ultimately, targeting lipid metabolism in macrophages can improve the outcome of metabolic diseases. Here, we review the main aspects of macrophage immunometabolism from the perspective of the metabolism of lipids. Building a reliable metabolic network during macrophage activation will bring us closer to targeting macrophages for improving human health.

1 October 2005 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
MVMaricel Vidal
Maricel Vidal
EKEileen Kruger
Eileen Kruger
CDClaudia Durán
Claudia Durán
RLRosanna Lagos
Rosanna Lagos
MLMyron Levine
Myron Levine
Roberto VidalRoberto Vidal
Roberto Vidal
We designed a multiplex PCR for the detection of all categories of diarrheagenic Escherichia coli . This method proved to be specific and rapid in detecting virulence genes from Shiga toxin-producing ( stx 1 , stx 2 , and eae ), enteropathogenic ( eae and bfp ), enterotoxigenic ( stII and lt ), enteroinvasive ( virF and ipaH ), enteroaggregative ( aafII ), and diffuse adherent ( daaE ) Escherichia coli in stool samples.

15 December 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SPSandra Panchalingam
Sandra Panchalingam
MAMartin Antonio
Martin Antonio
AHAnowar Hossain
Anowar Hossain
IMInacio Mandomando
Inacio Mandomando
BOBen Ochieng
Ben Ochieng
JNJames P. Nataro
James P. Nataro
To understand the etiology of moderate-to-severe diarrhea among children in high mortality areas of sub-Saharan Africa and South Asia, we performed a comprehensive case/control study of children aged <5 years at 7 sites. Each site employed an identical case/control study design and each utilized a uniform comprehensive set of microbiological assays to identify the likely bacterial, viral and protozoal etiologies. The selected assays effected a balanced consideration of cost, robustness and performance, and all assays were performed at the study sites. Identification of bacterial pathogens employed streamlined conventional bacteriologic biochemical and serological algorithms. Diarrheagenic Escherichia coli were identified by application of a multiplex polymerase chain reaction assay for enterotoxigenic, enteroaggregative, and enteropathogenic E. coli. Rotavirus, adenovirus, Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by commercially available enzyme immunoassays on stool samples. Samples positive for adenovirus were further evaluated for adenovirus serotypes 40 and 41. We developed a novel multiplex assay to detect norovirus (types 1 and 2), astrovirus, and sapovirus. The portfolio of diagnostic assays used in the GEMS study can be broadly applied in developing countries seeking robust cost-effective methods for enteric pathogen detection.

5 January 2019 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
David A. MonteroDavid A. Montero
David A. Montero
CACarolina Arellano
Carolina Arellano
MPMirka Pardo
Mirka Pardo
RVRosa Vera
Rosa Vera
RGRicardo Gálvez
Ricardo Gálvez
Roberto VidalRoberto Vidal
Roberto Vidal
Healthcare-associated infections (HAIs) have a major impact on public health worldwide. Particularly, hospital surfaces contaminated with bacterial pathogens are often the origin of both sporadic cases and outbreaks of HAIs. It has been demonstrated that copper surfaces reduce the microbial burden of high touch surfaces in the hospital environment. Here we report the antimicrobial characterization of a novel composite coating with embedded copper particles, named Copper Armour™. The Copper Armour™ bactericidal activity was evaluated in in vitro assays against several bacterial pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli O157:H7 and Listeria monocytogenes. Additionally, its antimicrobial properties were also evaluated in a pilot study over a nine-week period at an adult intensive care unit. For this, four high touch surfaces, including bed rails, overbed table, bedside table and IV Pole, were coated with Cooper Armour™, and its microbial burden was determined over a nine-week period. Copper Armour™ coated samples showed an in vitro reduction in bacterial burden of > 99.9% compared to control samples. Moreover, pilot study results indicate that Copper Armour™ significantly reduces the level of microbial contamination on high-touch surfaces in the hospital environment, as compared with standard surfaces. Based on its antimicrobial properties, Copper Armour™ is a novel self-sanitizing coating that exhibits bactericidal activity against important human pathogens and significantly reduces the microbial burden of hospital surfaces. This composite could be used as a self-sanitizing coating to complement infection control strategies in healthcare facilities.

1 May 2014 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
MFMarjorie De la Fuente
Marjorie De la Fuente
LFLuigi Franchi
Luigi Franchi
DADaniela Araya
Daniela Araya
DDDavid Díaz-Jiménez
David Díaz-Jiménez
MOMauricio Olivares
Mauricio Olivares
MHMarcela Hermoso
Marcela Hermoso

30 April 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
David A. MonteroDavid A. Montero
David A. Montero
MBMarcia Bodero
Marcia Bodero
GRGuillermina Riveros
Guillermina Riveros
LLLisette Lapierre
Lisette Lapierre
AGAldo Gaggero
Aldo Gaggero
MVMaricel Vidal
Maricel Vidal
Listeria monocytogenes is a pathogen transmitted through food that can cause severe infections in high-risk groups such as pregnant women, elderly, young children and immunocompromised individuals. It is a ubiquitous bacterium that can survive in harsh conditions, such as dry environments, at low temperatures, in brine conditions and at low pH values. It also has the capacity to form biofilms, which makes it particularly successful even in colonizing surfaces within food processing plants. This study analyzed the presence of L. monocytogenes in ready-to-eat food (RTE) such as sausage, cheese, fresh salads and other types of raw food. 850 samples of refrigerated and packaged food collected in 2008 and 2009 were analyzed. It was found that 25% of these samples were contaminated with L. monocytogenes strains. Serotyping and virulence genes detection by polymerase chain reaction (PCR) identified that strains belonging to serotype 4b, and containing one or more genes encoded by LIPI-1, were significantly associated with specific food types. Furthermore, using pulse field gel electrophoresis (PFGE), it was possible to associate isolates from cheese with strains from clinical cases of listeriosis outbreaks that occurred during the same time period within the same geographic regions. In addition, a strong correlation was observed between isolates from frozen seafood and from clinical strains obtained from sporadic cases of listeriosis. In agreement with reports described in other countries, our results shown that Chilean strains of L. monocytogenes from food products include the most virulent serotypes, encoding for the main virulence genes of the LIPI-1 pathogenicity island, and were clonally related to clinical isolates from sporadic cases and outbreaks of listeriosis. In conclusion, we show that Chilean isolates of L. monocytogenes from RTE and raw food products can cause disease in humans, representing a public health risk that justifies permanent surveillance.